ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

MEDS TRxADE HEALTH Inc

6,29
0,28 (4,66%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
TRxADE HEALTH Inc MEDS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,28 4,66% 6,29 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,02 6,02 6,42 6,29 6,01
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
23.4.202422:05GLOBETRxADE Health, Inc. Announces Receipt of Notice from Nasdaq..
06.3.202414:30EDGAR2Form 8-K - Current report
06.3.202414:05GLOBETRxADE Health, Inc. Announces Special Cash Dividend
26.2.202418:00EDGAR2Form SEC STAFF ACTION - SEC Staff Action: ORDER
16.2.202423:05EDGAR2Form 8-K - Current report
14.2.202420:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17.1.202415:07GLOBETrxade health, Inc files its 3Q 10Q
17.1.202415:05EDGAR2Form 8-K - Current report
16.1.202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16.1.202412:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202423:25EDGAR2Form 8-K - Current report
30.11.202300:13GLOBETRxADE Announces Receipt of Notification of Deficiency from..
28.11.202318:29EDGAR2Form 8-K - Current report
15.11.202319:51EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
17.10.202314:05GLOBETrxADE Health, Inc. affirms its commitment to the..
13.10.202319:25EDGAR2Form 8-K - Current report
12.10.202314:05GLOBESuperlatus Announces Distribution Partnership with North..
11.10.202322:05EDGAR2Form 8-K - Current report
04.10.202315:29EDGAR2Form 8-K - Current report
04.10.202314:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Acquires the..
25.9.202314:06EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
14.9.202323:28EDGAR2Form 8-K - Current report
08.9.202316:42EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
07.9.202314:05GLOBESuperlatus Announces Planned Expansion into Pet Food Market
25.8.202312:15EDGAR2Form 8-K - Current report
24.8.202315:47EDGAR2Form 8-K - Current report
24.8.202314:05GLOBESuperlatus Innovates $151 Billion US Snacking Market with..
22.8.202314:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Agrees to..
18.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202316:25GLOBETRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
14.8.202314:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14.8.202312:20EDGAR2Form PRE 14A - Other preliminary proxy statements
03.8.202315:05GLOBENewly merged Entity Superlatus, Inc with Trxade Health, Inc...
31.7.202315:40EDGAR2Form 8-K - Current report
31.7.202314:35GLOBETRxADE HEALTH, Inc. Announces Closing of Acquisition of..
14.7.202323:08EDGAR2Form 425 - Prospectuses and communications, business..
14.7.202323:07EDGAR2Form 8-K - Current report
14.7.202322:30GLOBETRxADE HEALTH, Inc. Amends Definitive Merger Agreement with..
10.7.202322:58EDGAR2Form 8-K - Current report
30.6.202315:25EDGAR2Form 425 - Prospectuses and communications, business..
30.6.202315:25EDGAR2Form 8-K - Current report
30.6.202314:05GLOBESuperlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive..
27.6.202314:00GLOBESuperlatus, Inc. Announces New Appointments to the..
23.6.202322:40GLOBETRxADE HEALTH, Inc. Issues Correction to Press Release..
23.6.202314:05GLOBESuperlatus, Inc. to Combine with TRxADE HEALTH, Inc., to..
21.6.202318:36GLOBETRxADE Health, Inc.’s Board of Directors Approves Reverse..
15.5.202322:15GLOBETRxADE HEALTH Reports First Quarter Gross Margin of 69% and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock